Coegin Pharma AB (NGM:COEGIN)
Sweden
· Delayed Price · Currency is SEK 3.750
+0.040 (1.08%)
At close: Mar 9, 2026
Coegin Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Cash & Equivalents | 7.92 | 19.68 | 5.55 | 3.82 | 25.66 | Upgrade
|
| Cash & Short-Term Investments | 7.92 | 19.68 | 5.55 | 3.82 | 25.66 | Upgrade
|
| Cash Growth | -59.74% | 254.70% | 45.39% | -85.13% | 54.12% | Upgrade
|
| Other Receivables | 0.58 | 1.15 | 0.64 | 3.13 | 4.64 | Upgrade
|
| Receivables | 0.58 | 1.15 | 0.64 | 3.13 | 4.64 | Upgrade
|
| Prepaid Expenses | 0.27 | 0.01 | 0.02 | 0.02 | 0.03 | Upgrade
|
| Other Current Assets | 1.23 | -0 | - | - | - | Upgrade
|
| Total Current Assets | 10 | 20.84 | 6.21 | 6.97 | 30.33 | Upgrade
|
| Property, Plant & Equipment | 0.11 | 0.15 | 0.3 | 0.49 | 0 | Upgrade
|
| Long-Term Investments | 0.06 | - | - | - | - | Upgrade
|
| Other Intangible Assets | 3.18 | 6.05 | 8.92 | 11.79 | - | Upgrade
|
| Other Long-Term Assets | - | - | - | 10 | - | Upgrade
|
| Total Assets | 13.34 | 27.04 | 15.43 | 29.25 | 30.34 | Upgrade
|
| Accounts Payable | 0.64 | 0.98 | 1.79 | 2 | 9.73 | Upgrade
|
| Accrued Expenses | 2.59 | 0.66 | 2.66 | 1.71 | 0.22 | Upgrade
|
| Current Income Taxes Payable | 0.02 | - | - | 0.18 | - | Upgrade
|
| Other Current Liabilities | 5.35 | 0.15 | 4.24 | 4.34 | 0.31 | Upgrade
|
| Total Current Liabilities | 8.6 | 1.78 | 8.68 | 8.23 | 10.26 | Upgrade
|
| Total Liabilities | 8.6 | 1.78 | 8.68 | 8.23 | 10.26 | Upgrade
|
| Common Stock | 12.44 | 12.44 | 4.7 | 35.33 | 27.57 | Upgrade
|
| Additional Paid-In Capital | 136.2 | 136.2 | 101.6 | 94.76 | 66.38 | Upgrade
|
| Retained Earnings | - | - | - | - | -75.07 | Upgrade
|
| Comprehensive Income & Other | -143.9 | -123.38 | -99.54 | -109.08 | 1.2 | Upgrade
|
| Shareholders' Equity | 4.74 | 25.26 | 6.75 | 21.01 | 20.07 | Upgrade
|
| Total Liabilities & Equity | 13.34 | 27.04 | 15.43 | 29.25 | 30.34 | Upgrade
|
| Net Cash (Debt) | 7.92 | 19.68 | 5.55 | 3.82 | 25.66 | Upgrade
|
| Net Cash Growth | -59.74% | 254.70% | 45.39% | -85.13% | 54.12% | Upgrade
|
| Net Cash Per Share | 0.32 | 1.04 | 0.60 | 0.56 | 4.32 | Upgrade
|
| Filing Date Shares Outstanding | 24.64 | 24.88 | 9.39 | 6.94 | 6.94 | Upgrade
|
| Total Common Shares Outstanding | 24.64 | 24.88 | 9.39 | 6.94 | 6.94 | Upgrade
|
| Working Capital | 1.4 | 19.06 | -2.47 | -1.26 | 20.07 | Upgrade
|
| Book Value Per Share | 0.19 | 1.02 | 0.72 | 3.03 | 2.89 | Upgrade
|
| Tangible Book Value | 1.56 | 19.21 | -2.17 | 9.22 | 20.07 | Upgrade
|
| Tangible Book Value Per Share | 0.06 | 0.77 | -0.23 | 1.33 | 2.89 | Upgrade
|
| Machinery | - | 0.63 | 0.64 | 0.68 | 0.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.